Treatment of Chronic Deep Vein Thrombosis (DVT) and Post-Thrombotic Syndrome (PTS) With the EkoSonic® Endovascular System
Public ClinicalTrials.gov record NCT02159521. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
ACCElerated ThrombolySiS for Post-Thrombotic Syndrome Using the EKOS System
Study identification
- NCT ID
- NCT02159521
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Boston Scientific Corporation
- Industry
- Enrollment
- 81 participants
Conditions and interventions
Conditions
Interventions
- EkoSonic® Endovascular System Device
- Alteplase Biological
Device · Biological
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 9, 2014
- Primary completion
- Nov 29, 2017
- Completion
- Nov 29, 2017
- Last update posted
- Jul 18, 2021
2014 – 2017
United States locations
- U.S. sites
- 22
- U.S. states
- 17
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UCLA Medical Center | Los Angeles | California | 90024 | — |
| University of Colorado Hospital | Aurora | Colorado | 80045 | — |
| Vascular Breakthroughs | Darien | Connecticut | 06820 | — |
| Christiana Hospital | Newark | Delaware | 19718 | — |
| Tampa General Hospital | Tampa | Florida | 33606 | — |
| Piedmont Atlanta Hospital | Atlanta | Georgia | 30309 | — |
| Medical Center of Central Georgia | Macon | Georgia | 31201 | — |
| University of Louisville Research Foundation | Louisville | Kentucky | 40202 | — |
| Ochsner Medical Center | New Orleans | Louisiana | 70121 | — |
| Maine Medical Center | Portland | Maine | 04106 | — |
| University of Michigan Medical Center | Ann Arbor | Michigan | 48109 | — |
| CHI Health St. Elizabeth | Lincoln | Nebraska | 68510 | — |
| Holy Name Medical Center | Teaneck | New Jersey | 07666 | — |
| NYU Langone Medical Center | New York | New York | 10016 | — |
| Weill Cornell Medical Center | New York | New York | 10024 | — |
| Aultman Hospital | Canton | Ohio | 44708 | — |
| Fairfield Medical Center | Lancaster | Ohio | 43130 | — |
| Oregon Health & Science University | Portland | Oregon | 97239 | — |
| DFW Vascular Group/ Methodist Dallas Medical Ctr | Dallas | Texas | 75208 | — |
| Houston Methodist Sugar Land Hospital | Sugar Land | Texas | 77479 | — |
| Inova Alexandria Hospital | Alexandria | Virginia | 22304 | — |
| Sentara Norfolk General Hospital | Norfolk | Virginia | 23507 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02159521, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 18, 2021 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02159521 live on ClinicalTrials.gov.